Natural Alternative to Weight Loss Injections? What the Evidence Says (October 2026)

01 · The short verdict

Is there a natural alternative to weight loss injections?

No natural product has been shown to replicate what a licensed weight loss injection does. Mounjaro (tirzepatide) activates two gut-hormone receptors, GIP and GLP-1, which help regulate appetite and slow stomach emptying.¹ Supplements marketed as "natural GLP-1" are not medicines, are not regulated for this use and have no comparable trial evidence.¹

That does not make food and lifestyle pointless. Every licensed weight loss medicine is used alongside a reduced-calorie diet and increased physical activity, so those habits are part of the plan either way.² What they cannot do is stand in for the medicine and be expected to produce the same trial-level results.

If you want the longer comparison, our guide to Mounjaro versus natural weight loss goes through it in detail. If you are looking for something without a needle, see our page on a over-the-counter alternative to Mounjaro.

02 · Side by side

Natural, over-the-counter and licensed options compared

03 · Deciding

How to decide what to do next

Start with what you actually want: a way to support healthier habits, or a treatment with trial-level evidence. If it is the first, food and activity changes are free to begin and carry no prescription. If it is the second, a licensed medicine is the route, and the question becomes which one suits your health profile.

Three practical questions help. First, do you meet the licensed criteria for a weight-management medicine? Your prescriber decides this in a consultation. Second, would you rather inject weekly, inject daily or take a tablet? Third, how do you feel about the cost and the commitment of a long course? Mounjaro's 2.5mg starter pen costs £169.99 per month at the standard price, and the 2.5mg to 15mg range is in stock through official LillyDirect supply. See the Mounjaro pen.

You do not have to decide alone. Our free online consultation is reviewed by a GPhC-registered prescriber, costs nothing and carries no obligation. If treatment is not suitable, you are refunded automatically in full. For a wider view of choices, see all weight loss treatments or our guide to other routes beyond injections.

04 · Why "natural GLP-1" falls short

Why "natural GLP-1" claims fall short of a medicine

Weight loss injections work by acting on specific hormone receptors, and that is exactly what a food or supplement cannot be shown to copy. Tirzepatide, the active ingredient in Mounjaro, is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.¹

In practice, most people on the medicine feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Notice what is being described: a medicine taken at a defined dose, with a known schedule, tested in large trials. Dosing for supplements is not standardised, and there is no equivalent body of trial evidence behind them.

The body does make its own GLP-1, and eating affects appetite in everyday ways. But the leap from "your body makes a hormone" to "this food gives the same result as an injection" is exactly where marketing runs ahead of evidence.

There is a second reason for caution. Ozempic itself is semaglutide licensed for type 2 diabetes, not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label.¹ The licensed weight-management injections are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg).¹ A regulated UK pharmacy will not supply Ozempic for weight loss, so anyone offering it that way is outside the regulated route.

Finally, think about what "natural" signals. It describes where something comes from, not whether it is tested, standardised or safe for you. A product can be plant-derived and still have no weight-loss evidence, no quality oversight and no one checking how it interacts with your other medicines. If you take any regular medicine, ask a pharmacist before starting a supplement. That is a safer first step than any online claim.

The practical takeaway is that the phrase "natural alternative to weight loss injections" describes a hope more than a product. The honest version is this: food and activity are the foundation, licensed medicines are the evidence-based addition, and supplements marketed as copies of those medicines sit in neither camp.

05 · Food and lifestyle changes

What food and lifestyle changes can realistically do

Lifestyle changes are worth doing, but the trial data gives them a clear, modest place. In SURMOUNT-1, which enrolled 2,539 adults, the comparison group using lifestyle changes alone lost on average 3.1% of body weight over 72 weeks.² People taking tirzepatide alongside diet and exercise lost on average 15% on 5mg, 19.5% on 10mg and 20.9% on 15mg.² These are trial averages, and individual results vary.

For someone starting at 100 kg, 3.1% is about 3 kg and 20.9% is about 21 kg. That worked example is simple arithmetic on the trial averages, not a prediction of your own result, but it shows why people who have tried diet and exercise carefully, and still struggled, ask about medicines.

That is not a reason to skip the basics. Every licensed treatment is used alongside a reduced-calorie diet and increased physical activity, not instead of them.² If you are building habits first, sensible starting points include planning regular meals, paying attention to portions, moving more through the week, and keeping a record of what you eat so patterns become visible. A pharmacist, GP or registered dietitian can tailor this to you, which is better than copying a list of "GLP-1 foods" from the internet.

Be wary of any article that says specific foods will produce a hormone response strong enough to replace treatment. Eating well can help you feel satisfied and support a calorie reduction, and that is a worthwhile goal on its own terms. It is not a licensed treatment, and nobody can promise it will deliver an injection-like result.

If you do start a medicine, food choices still matter. Mounjaro's most common side effects are digestive, and people often find that smaller meals, eating more slowly and noticing fullness sooner make the early weeks more comfortable. Your prescriber and our aftercare team can talk through what suits you.

Progress takes time whichever route you take. Weight loss on Mounjaro is gradual by design, and trials measured results at 72 weeks, so think in months rather than days and judge progress by trend rather than individual weigh-ins.¹ The same patience applies to lifestyle-only approaches. To compare the two paths side by side, read our comparison of Mounjaro and natural weight loss.

06 · Supplements and "poor man's Ozempic"

Supplements and the "poor man's Ozempic" label

"Poor man's Ozempic" is a nickname used in marketing, not the name of a medicine. It is attached to low-cost supplements, with berberine the best-known example, and to some fibre products. The label implies equivalence with a prescription injection, and that implication is the problem. Supplements such as berberine are not medicines, are not regulated for this use and have no comparable trial evidence.¹

Because these products are available cheaply without assessment, nobody checks whether they are right for you, whether they interact with your other medicines or whether the product contains what the label says. Dosing is not standardised, so check with a pharmacist before taking any supplement. If you are considering any supplement, speak to a pharmacist first.

• Dramatic weight-loss claims with no named, peer-reviewed trial behind them.
• Comparisons to prescription medicines, which suggest the same effect without the same evidence.
• Promises of specific results or timescales, which no responsible provider can make.
• "Natural" used as a stand-in for "safe" or "tested".

A related risk is "stacking". Mounjaro must not be combined with other GLP-1 medicines, unlicensed "research" peptides (such as retatrutide, which has no UK licence) or compounded copies.¹ These combinations have no safety data and no regulated supply chain. If something promises faster results outside a licensed pathway, that is the warning sign.¹

Counterfeit and unregulated products are a real concern for injectables too. The MHRA publishes counterfeit medicine alerts, and you can report a suspected side effect or a suspicious product through its Yellow Card scheme.⁷ Check that any pharmacy is on the GPhC register; ours is GPhC-registered (9012878), and Mounjaro is supplied through official LillyDirect supply from Eli Lilly's UK distribution, as genuine KwikPens. Be cautious of anyone offering to supply a prescription medicine without a consultation or prescription.

If you want a product you can buy without a prescription, that is a legitimate question, and our guide to the over-the-counter alternative to Mounjaro covers what is and is not available. The short version: nothing sold without a prescription has been shown to match a licensed GLP-1 medicine.

07 · Licensed non-natural alternatives

Licensed alternatives to weight loss injections

If what you really want is a different route, several licensed options exist besides Mounjaro. Each has its own eligibility checks, dosing and trial results, and each needs a prescriber's judgement about whether it suits you.

Wegovy (semaglutide) is a once-weekly injection. The pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, and the dose steps up after at least 4 weeks, reaching the 2.4mg maintenance dose from week 17. The 2.4mg dose is the licensed maintenance dose for weight management. You can view the Wegovy pen for current details.

Saxenda (liraglutide) is a daily injection, unlike once-weekly Mounjaro and Wegovy. Liraglutide is supplied at a concentration of 6mg per millilitre. For efficacy figures, your prescriber can advise.

Orlistat is a tablet that blocks some dietary fat absorption and produces smaller average losses than the GLP-1 medicines.¹

GLP-1 tablets. There is no tablet form of Mounjaro; tirzepatide is injection-only in the UK.¹ Two GLP-1 weight-loss tablets are now licensed: Wegovy tablets (oral semaglutide, made by Novo Nordisk), approved by the MHRA in June 2026, and Foundayo (orforglipron, made by Eli Lilly), approved in August 2026.¹ They are different medicines from Mounjaro, with their own dosing, eligibility checks and trial results, and both are prescription-only.

How you take each tablet is different, and it matters:

• Wegovy tablets: take on an empty stomach after fasting for at least 8 hours, swallowed whole with a sip of water (up to half a glass, about 120ml), then wait at least 30 minutes before eating, drinking or taking other tablets.²⁰
• Foundayo: any time of day, with or without food and without water restrictions, swallowed whole.²¹

If you use the contraceptive pill, Foundayo may make oral contraceptive pills less effective: switch to a non-oral method or add a barrier method for 30 days after starting and for 30 days after each dose increase.

The tablets' trial results should not be set against Mounjaro's, because they come from different trials and are not head-to-head. Which option fits depends on your health profile, how you tolerate the medicine and your prescriber's advice. Our page on NHS and private injection alternatives gives more background on the injection routes.

08 · Mounjaro versus Wegovy evidence

What the trial evidence shows for the licensed injections

For the licensed injections, there is real trial data, and it is worth reading carefully because it shows what a medicine does that supplements have never been tested to do. Every figure here is a trial average, and individual results vary.

SURMOUNT-1 (2,539 adults): people taking tirzepatide alongside diet and exercise lost on average 15% of body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, against 3.1% with lifestyle changes alone.² At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20%.²

STEP 1: adults on semaglutide 2.4mg (Wegovy) lost on average 14.9% of body weight over 68 weeks, compared with 2.4% on placebo.⁹

SURMOUNT-5, the first large head-to-head trial of tirzepatide and semaglutide for weight loss, is the only one of these that supports a direct comparison. Across 751 adults over 72 weeks, average loss was 20.2% of body weight on tirzepatide versus 13.7% on semaglutide 2.4mg.¹⁵ Average loss in kilograms was 22.8 kg versus 15.0 kg. At least 10% of body weight was lost by 81.6% on tirzepatide versus 60.5% on semaglutide; at least 15% by 64.6% versus 40.1%; at least 20% by 48.4% versus 27.3%; and at least 25% by 31.6% versus 16.1%.¹⁵

Both are effective, licensed treatments. Which suits you depends on your health profile, tolerance and prescriber advice, not the headline number alone.¹⁵ Trial averages do not predict your own result, and treatment works alongside a reduced-calorie diet and increased physical activity.²

Pace matters too. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward.¹ Your prescriber reviews response: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, they will discuss whether continuing or stopping is right for you.¹

For a deeper look at the two injections, see our guide to registering for weight loss injections online.

09 · Safety and side effects

Safety: are there dangers in taking GLP-1 medicines?

Yes, like all medicines, GLP-1 medicines can cause side effects, and most are digestive. For Mounjaro, the most common effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³ Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions.¹³ They are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹³

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for:

• severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis);
• pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems);
• signs of a severe allergic reaction, such as swelling of the face or throat and difficulty breathing.¹³

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion); your prescriber may need to adjust those medicines.¹³ If you feel chest pain, a racing heart or faintness, get medical help straight away.

Contraception. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. Switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase. This applies to the pill only; implants, coils and injections are unaffected.⁷

Who should not take it. Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. Mounjaro is prescription-only and supplied only after a consultation reviewed by a GPhC-registered prescriber, which is how contraindications and your other medicines are checked.¹ Not everyone is suitable, and if treatment is not right for you, a declined consultation is refunded automatically in full.

The comparison with supplements is stark. A prescription medicine comes with a patient information leaflet, known side-effect frequencies and a prescriber monitoring you. A supplement with no regulated weight-loss use offers none of that. Report any suspected side effect, from any product, to the MHRA through the Yellow Card scheme.¹⁹

As for "what is the safest GLP-1 to take", no medicine is safest for everyone. The right one depends on your health history, other medicines and tolerance, which is exactly what a prescriber assesses. Our free consultation is the place to start.

10 · NHS versus private

NHS or private: how to get a licensed treatment

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. The NHS guide to tirzepatide is a good first read.⁵

NHS access to Wegovy runs through specialist weight-management services; ask your GP. If you do not yet qualify, or would rather not wait, a private pharmacy route is available.

How ordering works with us. The process has four steps:

• Free online consultation: a short health questionnaire, no charge, no obligation.
• Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and dispatch: dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm.
• Delivery: free next-day tracked delivery in temperature-controlled, discreet packaging. Saturday delivery is £14.99.

Support is available Monday to Friday, 9am to 5pm, and ongoing monthly reviews, dose titration and follow-up assessments come from the prescribing team. Repeat orders re-check suitability, and nothing ships automatically. Needles, a sharps bin and injection guidance are included with every order.

Planning costs. At standard prices, the first four pens (2.5mg, 5mg, 7.5mg and 10mg) cost £959.96. A first year of 13 pens costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg. For other maintenance doses, the monthly standard price is £279.99 at 7.5mg, £290.99 at 10mg and £319.99 at 12.5mg. These totals are at standard prices; your first order and every later order are discounted at the current rates shown live on the product page. Prices were checked 10 October 2026.

Payment is by Visa or Mastercard, Klarna or pay-monthly options, with no subscription. You can see prices and begin on the Mounjaro pen page. GLPTrackr, our free companion app for iOS and Android, lets you track your GLP-1 journey.

11 · Using treatment day to day

What using a weight loss injection involves day to day

If you are weighing natural options against an injection, it helps to know what the injection routine actually looks like. For Mounjaro, everyone starts on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹ Many people settle at 5mg, 10mg or 15mg; higher is not automatically better, and your prescriber will guide the pace.

Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food. Licensed sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection. Rotate the site with each dose. Each KwikPen contains four weekly doses.¹ There is no "best" time of day; what matters is the same day each week, and many people choose a weekend morning so early side effects fall on days off.

Missed doses. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on as usual. If more than 4 days have passed, skip it and take the next on your normal day; never take two doses within 3 days of each other.¹ You can change your injection day as long as at least 3 days (72 hours) have passed since your last dose.

Storage and travel. Keep pens in a fridge at 2 to 8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, after which it should be discarded. Keep the cap on to protect it from light, and never use a pen that has been frozen.¹ You can fly with Mounjaro: carry pens in hand luggage, ideally in a cool bag with the prescription label or a copy of your prescription, and check destination rules before you travel.

Stopping. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4 to 5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

This is a medicine with a routine, clinical review and known safety information. Mounjaro is a prescription-only medicine used alongside a reduced-calorie diet and increased physical activity, and individual results vary. This page is information, not a substitute for medical advice. Speak to a prescriber about what suits you.